Category - Announcements

Pacific Biosciences Announces $900 Million Investment from SoftBank to Support Growth Initiatives

Personal Genome Diagnostics Announces Close of $103 Million Series C Financing

Sema4, a Disruptive AI-driven Genomic & Clinical Data Platform Company, to Combine with CM Life Sciences to Accelerate Growth

Tempus Launches Hereditary Cancer Germline Assay, xG

Next-Gen Proteomics Company Nautilus Biotechnology to List on Nasdaq Through Merger with Arya Sciences Acquisition Corp III

Illumina Accelerator Invests in Nine Genomics Startups for Second Global Cycle

23andMe to Merge with Virgin Group’s VG Acquisition Corp. to Become Publicly-Traded Company Set to Revolutionize Personalized Healthcare and Therapeutic Development through Human Genetics

Veracyte to Acquire Decipher Biosciences

Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology

Quest Diagnostics Granted CDC Contract to Sequence COVID-19 Gene Variants to Aid Public Health Response to COVID-19

Personal Genome Diagnostics and QIAGEN Collaborate to Offer Integrated Genomic Testing and Interpretation Support

Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform

Helix® Laboratory Platform Granted the First and Only FDA Authorization for a Whole Exome Sequencing Platform

NuProbe Closes $42M Fundraising

Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure

My Gene Counsel and Genomet Announce Product Partnership to Transform Cancer Care Around the Globe

Copyright © 2026. enlighenbio LLC. All rights reserved.